An analysis of 27 years of “ongoing, systematic wrongdoing” by the pharmaceutical industry reveals the U.S. Department of Justice has levied billions of dollars worth of fines against pharma companies, often under the False Claims Act. The fines support government budgets but do nothing to reform the industry’s criminal behavior.